华熙生物上半年净利2.21亿元，同比下降35.38%

Core Viewpoint - Huaxi Biological (688363) reported a significant decline in both revenue and net profit for the first half of the year, indicating challenges in its skin science innovation business [1] Financial Performance - The company achieved operating revenue of 2.261 billion yuan, a year-on-year decrease of 19.57% [1] - The net profit attributable to shareholders was 221 million yuan, down 35.38% year-on-year [1] Business Strategy - The decline in net profit is primarily attributed to the decrease in revenue from the skin science innovation transformation business [1] - The company aims to continue its focus on technological innovation and the application of synthetic biology in more fields [1] - There is an emphasis on optimizing business structure and improving operational efficiency to achieve high-quality development goals [1]